市場調查報告書
商品編碼
1423286
按產品類型(纖維素、乳糖、多元醇、聚維酮、澱粉和多醣、共加工可壓縮輔料等)、應用(片劑和膠囊、基於溶液)和區域分類的粘合劑輔料市場報告2024- 2032Binder Excipients Market Report by Product Type (Cellulosics, Lactose, Polyols, Povidones, Starch and Polysaccharides, Co-Processed Compressible Excipients, and Others), Application (Tablets and Capsules, Solution Based), and Region 2024-2032 |
2023年全球黏合劑輔料市場規模達到15億美元。展望未來, IMARC Group預計到2032年市場規模將達到21億美元,2024-2032年複合年成長率(CAGR)為4%。大眾對口服藥物的需求不斷成長、對以患者為中心的配方的日益關注以及廣泛的研發活動是推動市場的一些關鍵因素。
黏合劑賦形劑是藥物製劑中的基本成分之一,特別是在固體口服劑型中使用時。它們用於結合片劑或膠囊的藥物活性物質和其他成分,從而產生穩定且易於管理的最終產品。它們是親水性分子,可以與配方中的其他成分(例如纖維素衍生物)產生有效的分子間相互作用。增強粉末混合物的可壓縮性是黏合劑賦形劑的主要目的之一,它為片劑或膠囊提供了可能的恆定尺寸和形狀,保證了一致且可預測的劑量。此外,它們還有助於增強粉末混合物的流動特性,從而更容易壓縮片劑或填充膠囊。它們還有助於控制活性成分的釋放,這是粘合劑賦形劑的另一個重要功能,並且它們有助於維持藥物的治療效果,這對於具有有限治療窗或僅被吸收的藥物至關重要。身體的某些部位。有多種類型的黏合劑賦形劑可用,包括天然和合成聚合物、糖和澱粉
患者對口服藥物不斷成長的需求主要推動了全球市場。這是因為它們具有多種優點,例如易於管理、方便和劑量準確,這些都推動了市場的發展。此外,許多製藥公司正在大力投資開發新的片劑和膠囊配方,這推動了對黏合劑賦形劑的需求。同時,人們越來越關注以患者為中心的配方,這些配方是為了提高患者的依從性和對藥物治療方案的依從性而設計的,這極大地支持了市場。與此一致的是,需要特殊黏合劑賦形劑的新型藥物遞送系統(例如緩釋片劑和膠囊)的開發也推動了這項需求。除此之外,對營養保健品(即具有健康益處的膳食補充劑)不斷成長的需求正在對市場產生有利的影響。此外,由於越來越多的品牌藥專利到期,對學名藥的需求不斷成長,這也對市場做出了貢獻。此外,新型輔料(例如共加工輔料)的開發正在創造積極的市場前景。推動市場的其他一些因素包括對創新療法的需求不斷成長以及醫療保健行業的持續改進。
The global binder excipients market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032. The increasing demand for oral medications among the masses, the growing focus on patient-centric formulations, and extensive research and development activities represent some of the key factors driving the market.
Binder excipients act as one of the essential components in pharmaceutical formulations, especially when utilized in solid oral dose forms. They are employed to bind the pharmaceutical active substances and other elements of a tablet or capsule, resulting in a stable and manageable final product. They are hydrophilic molecules that can generate potent intermolecular interactions with the other components of the formulation, such as cellulose derivatives. Enhancing the powder mixture's compressibility is one of the primary purposes of binder excipients, which provide tablets or capsules with the constant size and shape possible, guaranteeing a consistent and predictable dose. Additionally, they aid in enhancing the powder mixture's flow characteristics, making it simpler to compress tablets or fill capsules. They also aid in controlling the release of the active ingredient release is another crucial function of binder excipients as well as they help in maintaining the therapeutical effect of the medicinal drugs, which is crucial for medications to have a limited therapeutic window or are absorbed only in certain parts of the body. There are several types of binder excipients available, including natural and synthetic polymers, sugars, and starches
The escalating demand for oral medicines among the patients majorly drives the global market. This is due to their several benefits, such as easy administration, convenience, and accurate dosing, which are driving the market. In addition, numerous pharmaceutical companies are investing heavily in the development of new tablet and capsule formulations, which is propelling the demand for binder excipients. Along with this, the growing focus on patient-centric formulations, which are created to improve patient compliance and adherence to a medication regimen, is significantly supporting the market. In line with this, the development of novel drug delivery systems, such as modified-release tablets and capsules, requiring specialized binder excipients is also providing a thrust to the demand. Apart from this, the growing demand for nutraceuticals, which are dietary supplements that offer health benefits, is influencing the market favorably. In addition, the rising demand for generic drugs on account of the increasing number of patents expiring on branded drugs is contributing to the market. Furthermore, the development of novel excipients, such as co-processed excipients, is creating a positive market outlook. Some of the other factors driving the market include the rising demand for innovative therapies and continual improvements in the healthcare sector.
IMARC Group provides an analysis of the key trends in each sub-segment of the global binder excipients market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type and application.
Cellulosics
Lactose
Polyols
Povidones
Starch and Polysaccharides
Co-Processed Compressible Excipients
Others
The report has provided a detailed breakup and analysis of the binder excipients market based on the product type. This includes cellulosics, lactose, polyols, povidones, starch and polysaccharides, co-processed compressible excipients, and others. According to the report, cellulosics represented the largest segment.
Tablets and Capsules
Solution Based
A detailed breakup and analysis of the binder excipients market based on the application have also been provided in the report. This includes tablets and capsules and solution based. Amongst these, tablets and capsules represent the largest segment.
North America
Asia Pacific
Europe
Middle East and Africa
Latin America
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. According to the report, North America was the largest market for binder excipients. Some of the factors driving the North America binder excipients market included technological advancements, increasing investments in innovations, and significant growth in the pharmaceutical industry across the region.
The report has also provided a comprehensive analysis of the competitive landscape in the global binder excipients market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered are Colorcon, Croda International, EMD Millipore, Dow Chemical, FMC BioPolymer, Fuji Chemical Industry and Ingredion.